Sunovion Pharmaceuticals Inc
84 Waterford Drive
Marlborough
United States of America
84 Waterford Drive
Marlborough
United States of America
Phone: 1 508 4816700
Fax: 15-08-3577491
www.sunovion.com
Fax: 15-08-3577491
www.sunovion.com
Company Overview
Top Competitors
Key Employees
Nobuhiko Tamura
Chairman, Chief Executive Officer, Executive BoardAntony Loebel, M.D.
Chief Medical Officer, Executive Vice President, Head - Global Clinical Development, Senior ManagementMatthew D’Ambrosio
Chief Compliance and Ethics Officer, Senior Vice President, Senior ManagementRobert Gregorio
Chief Administrative Officer, Executive Vice President, Senior ManagementDavid Frawley
Chief Commercial Officer, Executive Vice President, Senior ManagementStephen Freeman
Chief Financial Officer, Senior Vice President, Senior ManagementGreg Bokar
Senior Vice President, Secretary - Corporate, General Counsel, Senior ManagementLocations/Subsidiaries
84 Waterford Drive,
Marlborough,
Massachusetts,
United States of America
Phone: 1 508 4816700
Fax: 1 508 3577491
Suite 510,
One Bridge Plaza North,
Fort Lee,
New Jersey,
United States of America
Cynapsus Therapeutics Inc
828 Richmond Street West,Toronto,
Ontario,
Canada
Phone: 1 416 7032449
Fax: 1 416 7038752
Sunovion Pharmaceuticals Canada Inc
Suite 100,6790 Century Avenue,
Mississauga,
Ontario,
Canada
Phone: 1 905 8149145
Fax: 1 905 3630162
Sunovion Pharmaceuticals Europe Ltd
First Floor, Southside,97-105 Victoria Street,
London,
England,
United Kingdom
Phone: 44 20 78212840
Fax: 44 20 78212841
Sunovion Respiratory Development Inc
84 Waterford Drive,Marlborough,
Massachusetts,
United States of America
Phone: 1 508 4816700
Fax: 1 508 3577491
Products/Services
Products:
- Eslicarbazepine Acetate Tablets
- Lurasidone HCL Tablets
- Eszopiclone Tablets
- Levalbuterol HCL Inhalation Solution
- Levalbuterol Tartrate Inhalation Aerosol
- Arformoterol Tartrate Inhalation Solution
- Ciclesonide Nasal Spray
- Ciclesonide Inhalation Aerosol
- Ciclesonide Nasal Aerosol
- Product Pipeline:
- WT-2725 - Hematologic and Solid Cancer
- SEP-856 - Schizophrenia and Parkinson’s Disease
- DSP-3748 - Cognitive Impairment associated with Schizophrenia
- DSP-2230 - Neuropathic Pain
- SB-623 - Chronic Stroke
- Dasotraline - Attention Deficit Hyperactivity Disorder
- SUN-101 - Chronic Obstructive Pulmonary Disease
- Latuda - Adolescent Schizophrenia and Adolescent Bipolar Depression
Services:
- Patient Assistance Program (PAP)
- Customer Assistance Service
